Zydus Animal Health and Investments Limited (ZAHL), a wholly-owned subsidiary of Zydus Life, has announced the sale of its 6.5% equity stake in Mylab Discovery Solutions Private Limited (Mylab) back to Rising Sun Holding Private Limited (RHSPL). The transaction has been executed at a consideration of ₹106 crore.
The decision follows the exercise of a Put Option by ZAHL as part of the Share Purchase Agreement (SPA) executed on June 23, 2023, between ZAHL, RHSPL, and Mylab. The termination deed was signed on December 16, 2024, marking the completion of the agreement.
Transaction Highlights:
- Stake Sold: 6.5% equity in Mylab Discovery Solutions.
- Buyer: Rising Sun Holding Private Limited (RHSPL).
- Consideration: ₹106 crore.
- Completion Timeline: Within 15 working days from the signing of the termination deed.
RHSPL, the buyer, is not part of the promoter group or related entities, and the deal does not fall under related-party transactions. This divestment aligns with ZAHL’s strategic plans while ensuring compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
With the transaction finalized, ZAHL continues to focus on optimizing its portfolio while maintaining shareholder interests.
